90 results
Search Results
2. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink
3. A paper-based immunoassay to determine HPV vaccination status at the point-of-care
4. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper
5. Tetanus vaccines: WHO position paper, February 2017 – Recommendations
6. BCG vaccine: WHO position paper, February 2018 – Recommendations
7. Cholera vaccine: WHO position paper, August 2017 – Recommendations
8. Diphtheria vaccine: WHO position paper, August 2017 – Recommendations
9. Human papillomavirus vaccines: WHO position paper, May 2017–Recommendations
10. Polio vaccines: WHO position paper, March 2016–recommendations
11. Pertussis vaccines: WHO position paper, August 2015—Recommendations
12. Malaria vaccine: WHO position paper, January 2016 – Recommendations
13. WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015
14. WHO position on the use of fractional doses – June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper – June 2013
15. Dengue vaccine: WHO position paper, July 2016 – recommendations
16. Reducing pain at the time of vaccination: WHO position paper, September 2015—Recommendations
17. Hepatitis E vaccine: WHO position paper, May 2015 – Recommendations
18. Japanese Encephalitis Vaccines: WHO position paper, February 2015 – Recommendations
19. Varicella and herpes zoster vaccines: WHO position paper, June 2014 – Recommendations
20. Human papillomavirus vaccines: WHO position paper, October 2014—Recommendations
21. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013—Recommendations
22. Polio vaccines: WHO position paper, January 2014 – Recommendations
23. Call for papers, Vaccine Congress, Celebrating 25 Years of Publication, 9-11 December 2007, Amsterdam, The Netherlands
24. Call for papers: viral vaccine meeting
25. Comments on the paper “The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data” [P. Rivest, R. Allard, Vaccine 20 (2002) 2533–2536]
26. Prevalence of influenza-specific vaccination hesitancy among adults in the United States, 2018
27. Strategies for financial sustainability of immunization programs: A review of the strategies from 50 national immunization program financial sustainability plans
28. Introducing new vaccines in the poorest countries: What did we learn from the GAVI experience with financial sustainability?
29. The GAVI Financing Task Force: One model of partner collaboration
30. A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults
31. Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus
32. Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data
33. Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data
34. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data
35. Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
36. Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
37. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
38. Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data
39. Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
40. Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
41. Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years
42. Reasons given for not receiving an influenza vaccination, 2011–12 influenza season, United States
43. Influenza vaccination coverage of Vaccine for Children (VFC)-entitled versus privately insured children, United States, 2011–2013
44. National and state-specific estimates of place of influenza vaccination among adult populations – United States, 2011–12 influenza season
45. Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel—United States, 2011
46. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors
47. Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond
48. After a tick bite in a tick-borne encephalitis virus endemic area: Current positions about post-exposure treatment
49. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth
50. Cost and cost-effectiveness of childhood vaccination against rotavirus in France
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.